Correlation Between Replimune and Kronos Bio
Can any of the company-specific risk be diversified away by investing in both Replimune and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Kronos Bio, you can compare the effects of market volatilities on Replimune and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Kronos Bio.
Diversification Opportunities for Replimune and Kronos Bio
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Replimune and Kronos is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Replimune i.e., Replimune and Kronos Bio go up and down completely randomly.
Pair Corralation between Replimune and Kronos Bio
Given the investment horizon of 90 days Replimune Group is expected to generate 1.79 times more return on investment than Kronos Bio. However, Replimune is 1.79 times more volatile than Kronos Bio. It trades about -0.05 of its potential returns per unit of risk. Kronos Bio is currently generating about -0.1 per unit of risk. If you would invest 1,233 in Replimune Group on December 30, 2024 and sell it today you would lose (194.00) from holding Replimune Group or give up 15.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Replimune Group vs. Kronos Bio
Performance |
Timeline |
Replimune Group |
Kronos Bio |
Replimune and Kronos Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Replimune and Kronos Bio
The main advantage of trading using opposite Replimune and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Kronos Bio vs. Mirum Pharmaceuticals | Kronos Bio vs. Rocket Pharmaceuticals | Kronos Bio vs. Avidity Biosciences | Kronos Bio vs. Uniqure NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |